Boomerang Ventures

BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.

Back to News Page

Press Release: Boomerang Ventures Leads Strategic Investment in IMPOWER HEALTH, Appoints Trent McCracken as CEO
Press Releases

Boomerang Ventures Leads Strategic Investment in IMPOWER HEALTH, Appoints Trent McCracken as CEO

Boomerang Ventures has led a strategic pre-seed investment in IMPOWER HEALTH, a mobility health startup transforming treadmills into clinical-grade gait diagnostics platforms. The Omaha-based company also appointed Trent McCracken as CEO as it advances commercialization and OEM partnerships. IMPOWER HEALTH’s technology captures objective, reimbursable gait variability data across rehabilitation and performance-focused fitness settings, positioning mobility as a measurable clinical biomarker.

Read More »
In the News
In The news

Boomerang Ventures Leads $3M Seed in SynchNeuro

Source: Indianapolis Business Journal
Boomerang Ventures has taken the lead in a $3 million seed round for SynchNeuro Inc., a Philadelphia-based health tech startup developing a wearable sensor that translates brainwave activity into real-time health insights. As part of the investment, Boomerang Founder and Managing Partner Oscar Moralez has joined the company’s board, strengthening the partnership as SynchNeuro advances its technology to monitor blood sugar and other critical health metrics.

Read More »
In the News
In The news

Boomerang Ventures Leads $2M Seed Round for SiteLabs

Source: Tech Point
“Independent pharmacies are an untapped infrastructure for improving healthcare access in America,” said Darren Schaupp, CEO of SiteLabs. “They know their communities, see patients regularly, and can close critical gaps in preventive care and research recruitment — if we give them the right tools and partnerships.” With its pioneering point-of-care platform, SiteLabs is enabling pharmacies to deliver diagnostic screenings, connect patients to clinical trials, and create new revenue streams while improving health outcomes. Led by Boomerang Ventures, SiteLabs just closed a $2 million seed round to transform neighborhood pharmacies into frontline hubs for preventive care and research participation.

Read More »

Back to News Page

Boomerang Ventures
Loading...